Literature DB >> 26400567

Podocyte Expression of B7-1/CD80: Is it a Reliable Biomarker for the Treatment of Proteinuric Kidney Diseases with Abatacept?

David J Salant1.   

Abstract

Entities:  

Keywords:  B7-1; CD80; CTLA4-Ig; abatacept; diabetic nephropathy; focal segmental glomerulosclerosis

Mesh：

Substances：

Year:  2015        PMID： 26400567      PMCID： PMC4814196          DOI： 10.1681/ASN.2015080947

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  14 in total

1.  B7-1 Is Not Induced in Podocytes of Human and Experimental Diabetic Nephropathy.

Authors:  Elena Gagliardini; Rubina Novelli; Daniela Corna; Carlamaria Zoja; Barbara Ruggiero; Ariela Benigni; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2015-08-28       Impact factor: 10.121

2.  A new era of podocyte-targeted therapy for proteinuric kidney disease.

Authors:  Börje Haraldsson
Journal:  N Engl J Med       Date:  2013-11-08       Impact factor: 91.245

3.  Abatacept in B7-1-positive proteinuric kidney disease.

Authors:  Chih-Chuan Yu; Alessia Fornoni; Astrid Weins; Samy Hakroush; Dony Maiguel; Junichiro Sageshima; Linda Chen; Gaetano Ciancio; Mohd Hafeez Faridi; Daniel Behr; Kirk N Campbell; Jer-Ming Chang; Hung-Chun Chen; Jun Oh; Christian Faul; M Amin Arnaout; Paolo Fiorina; Vineet Gupta; Anna Greka; George W Burke; Peter Mundel
Journal:  N Engl J Med       Date:  2013-11-08       Impact factor: 91.245

4.  Abatacept in B7-1-positive proteinuric kidney disease.

Authors:  Ariela Benigni; Elena Gagliardini; Giuseppe Remuzzi
Journal:  N Engl J Med       Date:  2014-03-27       Impact factor: 91.245

5.  B7-1 immunostaining in proteinuric kidney disease.

Authors:  Christopher P Larsen; Nidia C Messias; Patrick D Walker
Journal:  Am J Kidney Dis       Date:  2014-09-30       Impact factor: 8.860

6.  The B7-independent isoform of CTLA-4 functions to regulate autoimmune diabetes.

Authors:  Melanie Stumpf; Xuyu Zhou; Jeffrey A Bluestone
Journal:  J Immunol       Date:  2013-01-04       Impact factor: 5.422

7.  Role of podocyte B7-1 in diabetic nephropathy.

Authors:  Paolo Fiorina; Andrea Vergani; Roberto Bassi; Monika A Niewczas; Mehmet M Altintas; Marcus G Pezzolesi; Francesca D'Addio; Melissa Chin; Sara Tezza; Moufida Ben Nasr; Deborah Mattinzoli; Masami Ikehata; Domenico Corradi; Valerie Schumacher; Lisa Buvall; Chih-Chuan Yu; Jer-Ming Chang; Stefano La Rosa; Giovanna Finzi; Anna Solini; Flavio Vincenti; Maria Pia Rastaldi; Jochen Reiser; Andrzej S Krolewski; Peter H Mundel; Mohamed H Sayegh
Journal:  J Am Soc Nephrol       Date:  2014-03-27       Impact factor: 10.121

8.  US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States.

Authors:  Rajiv Saran; Yi Li; Bruce Robinson; John Ayanian; Rajesh Balkrishnan; Jennifer Bragg-Gresham; Joline T L Chen; Elizabeth Cope; Debbie Gipson; Kevin He; William Herman; Michael Heung; Richard A Hirth; Steven S Jacobsen; Kamyar Kalantar-Zadeh; Csaba P Kovesdy; Alan B Leichtman; Yee Lu; Miklos Z Molnar; Hal Morgenstern; Brahmajee Nallamothu; Ann M O'Hare; Ronald Pisoni; Brett Plattner; Friedrich K Port; Panduranga Rao; Connie M Rhee; Douglas E Schaubel; David T Selewski; Vahakn Shahinian; John J Sim; Peter Song; Elani Streja; Manjula Kurella Tamura; Francesca Tentori; Paul W Eggers; Lawrence Y C Agodoa; Kevin C Abbott
Journal:  Am J Kidney Dis       Date:  2015-07       Impact factor: 8.860

9.  Induction of B7-1 in podocytes is associated with nephrotic syndrome.

Authors:  Jochen Reiser; Gero von Gersdorff; Martin Loos; Jun Oh; Katsuhiko Asanuma; Laura Giardino; Maria Pia Rastaldi; Novella Calvaresi; Haruko Watanabe; Karin Schwarz; Christian Faul; Matthias Kretzler; Anne Davidson; Hikaru Sugimoto; Raghu Kalluri; Arlene H Sharpe; Jordan A Kreidberg; Peter Mundel
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

10.  CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance.

Authors:  Gabriel Cara-Fuentes; Changli Wei; Alfons Segarra; Takuji Ishimoto; Christopher Rivard; Richard J Johnson; Jochen Reiser; Eduardo H Garin
Journal:  Pediatr Nephrol       Date:  2013-11-22       Impact factor: 3.714
View more
  9 in total

Review 1.  Podocyte-actin dynamics in health and disease.

Authors:  Luca Perico; Sara Conti; Ariela Benigni; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2016-08-30       Impact factor: 28.314

2.  Interaction of CD80 with Neph1: a potential mechanism of podocyte injury.

Authors:  Bhavya Khullar; Renu Balyan; Neelam Oswal; Nidhi Jain; Amita Sharma; Malik Z Abdin; Arvind Bagga; Shinjini Bhatnagar; Nitya Wadhwa; Uma Chandra Mouli Natchu; Anna George; Satyajit Rath; Vineeta Bal; Shailaja Sopory
Journal:  Clin Exp Nephrol       Date:  2017-10-11       Impact factor: 2.801

Review 3.  Podocytes.

Authors:  Jochen Reiser; Mehmet M Altintas
Journal:  F1000Res       Date:  2016-01-28

4.  In IgA Nephropathy, Glomerulosclerosis Is Associated with Increased Urinary CD80 Excretion and Urokinase-Type Plasminogen Activator Receptor-Positive Podocyturia.

Authors:  Hernán Trimarchi; Romina Canzonieri; Amalia Schiel; Cristian Costales-Collaguazo; Aníbal Stern; Matías Paulero; Tatiana Rengel; José Andrews; Alejandro Iotti; Mariano Forrester; Fernando Lombi; Vanesa Pomeranz; Romina Iriarte; Alexis Muryan; Elsa Zotta
Journal:  Nephron Extra       Date:  2017-05-16

5.  The utility of urinary CD80 as a diagnostic marker in patients with renal diseases.

Authors:  Shogo Minamikawa; Kandai Nozu; Shingo Maeta; Tomohiko Yamamura; Keita Nakanishi; Junya Fujimura; Tomoko Horinouchi; China Nagano; Nana Sakakibara; Hiroaki Nagase; Hideaki Shima; Kenta Noda; Takeshi Ninchoji; Hiroshi Kaito; Kazumoto Iijima
Journal:  Sci Rep       Date:  2018-11-23       Impact factor: 4.379

6.  Urinary CD80 Discriminates Among Glomerular Disease Types and Reflects Disease Activity.

Authors:  Anatilde M Gonzalez Guerrico; John Lieske; George Klee; Sanjay Kumar; Victor Lopez-Baez; Adam M Wright; Shane Bobart; Diane Shevell; Michael Maldonado; Jonathan P Troost; Marie C Hogan
Journal:  Kidney Int Rep       Date:  2020-08-14

7.  Dual and Opposite Costimulatory Targeting with a Novel Human Fusion Recombinant Protein Effectively Prevents Renal Warm Ischemia Reperfusion Injury and Allograft Rejection in Murine Models.

Authors:  Jordi Guiteras; Laura De Ramon; Elena Crespo; Nuria Bolaños; Silvia Barcelo-Batllori; Laura Martinez-Valenzuela; Pere Fontova; Marta Jarque; Alba Torija; Oriol Bestard; David Resina; Josep M Grinyó; Joan Torras
Journal:  Int J Mol Sci       Date:  2021-01-26       Impact factor: 5.923

Review 8.  CD80 Insights as Therapeutic Target in the Current and Future Treatment Options of Frequent-Relapse Minimal Change Disease.

Authors:  Yoong Mond Teh; Soo Kun Lim; Norhana Jusoh; Kahar Osman; Siti Aisyah Mualif
Journal:  Biomed Res Int       Date:  2021-01-06       Impact factor: 3.411

9.  Dual Costimulatory and Coinhibitory Targeting with a Hybrid Fusion Protein as an Immunomodulatory Therapy in Lupus Nephritis Mice Models.

Authors:  Jordi Guiteras; Elena Crespo; Pere Fontova; Nuria Bolaños; Montse Gomà; Esther Castaño; Oriol Bestard; Josep M Grinyó; Joan Torras
Journal:  Int J Mol Sci       Date:  2022-07-29       Impact factor: 6.208
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.